Cita APA (7a ed.)
Kuhr, K., Wirth, D., Srivastava, K., Lehmacher, W., & Hellmich, M. (2016). First-line therapy for non-transplant eligible patients with multiple myeloma: Direct and adjusted indirect comparison of treatment regimens on the existing market in Germany. European Journal of Clinical Pharmacology, 72(3), 257-266.
Cita Chicago Style (17a ed.)
Kuhr, Kathrin, Daniel Wirth, Kunal Srivastava, Walter Lehmacher, y Martin Hellmich. "First-line Therapy for Non-transplant Eligible Patients with Multiple Myeloma: Direct and Adjusted Indirect Comparison of Treatment Regimens on the Existing Market in Germany." European Journal of Clinical Pharmacology 72, no. 3 (2016): 257-266.
Cita MLA (9a ed.)
Kuhr, Kathrin, et al. "First-line Therapy for Non-transplant Eligible Patients with Multiple Myeloma: Direct and Adjusted Indirect Comparison of Treatment Regimens on the Existing Market in Germany." European Journal of Clinical Pharmacology, vol. 72, no. 3, 2016, pp. 257-266.
Precaución: Estas citas no son 100% exactas.